Prescription opioid misuse and mental health among young injection drug users

References

• National Institute on Drug Abuse (NIDA). Prescription drugs: abuse and addiction. NIDA Research Report, NIH Publication Number 11-4881; Bethesda, MD; 2011
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). The NSDUH report: trends in nonmedical use of prescription pain relievers: 2002 to 2007; Rockville, MD: Office of Applied Studies; 2009
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Drug Abuse Warning Network, 2009: national estimates of drug-related emergency department visits. DAWN Series D-35, HHS Publication No. (SMA) 11-4659; Rockville, MD; 2011
   Google Scholar
• Cerdá M, Ransome Y, Keyes KM, Koenen KC, Tracy M, Tardiff KJ, Vlahov D, Galea S. Prescription opioid mortality trends in New York City, 1990–2006: examining the emergence of an epidemic. Drug Alcohol Depend 2013;132:53–62
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers – United States, 1999–2008. Morb Mortal Weekly Rep 2011;60:1487–1492
   PubMedGoogle Scholar
• Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief, Number 22; Hyattsville, MD: National Center for Health Statistics; 2009
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Treatment Episode Data Set (TEDS) highlights – 2007 National Admissions to Substance Abuse Treatment Services. OAS Series S-45; Rockville, MD: SAMHSA, Office of Applied Studies; 2009
   Google Scholar
• Peindl KS, Mannelli P, Wu LT, Patkar AA. Trends in nonheroin opioid abuse admissions: 1992–2004. J Opioid Manag 2007;3:215–223
   Google Scholar
• Fischer B, Nakamura N, Urbanoski K, Rush B, Rehm J. Correlations between population levels of prescription opioid use and prescription-opioid-related substance use treatment admissions in the USA and Canada since 2001. Public Health 2012;126:749–751
   PubMed Web of Science ®Google Scholar
• Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. “Every ‘never’ I ever said came true”: Transitions from opioid pills to heroin injecting. Int J Drug Policy 2013;25:257--266
   PubMed Web of Science ®Google Scholar
• Lankenau SE, Teti M, Silva K, Bloom JJ, Harocopos A, Treese M. Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy 2012;23:37–44
   PubMed Web of Science ®Google Scholar
• Grau LE, Dasgupta N, Harvey AP, Irwin K, Givens A, Kinzly ML, Heimer R. Illicit use of opioids: is OxyContin® a “gateway drug”? Am J Addict 2007;16:166–173
   PubMed Web of Science ®Google Scholar
• Pollini R, Banta-Green C, Cuevas-Mota J, Metzner M, Teshale E, Garfein R. Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Substance Abuse Rehabil 2011;2:173–180
   PubMedGoogle Scholar
• Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010. Drug Alcohol Depend 2013;132:95–100
   PubMed Web of Science ®Google Scholar
• Peavy KM, Banta-Green CJ, Kingston S, Hanrahan M, Merrill JO, Coffin PO. “Hooked on” prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients. J Psychoactive Drugs 2012;44:259–265
   PubMed Web of Science ®Google Scholar
• Broz D, Ouellet LJ. Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. Drug Alcohol Depend 2008;94:221–233
   PubMed Web of Science ®Google Scholar
• Khosla N, Juon HS, Kirk GD, Astemborski J, Mehta SH. Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City. Addict. Behav 2011;36:1282–1287
   PubMed Web of Science ®Google Scholar
• Al-Tayyib AA, Rice E, Rhoades H, Riggs P. Association between prescription drug misuse and injection among runaway and homeless youth. Drug Alcohol Depend 2014;134:406–409
   Google Scholar
• Lankenau SE, Teti M, Silva K, Bloom J, Harocopos A, Treese M. Patterns of prescription drug misuse among young injection drug users. J Urban Health 2012;89:1004–1016
   PubMed Web of Science ®Google Scholar
• West R, Brown J. Theory of addiction, 2nd ed. West Sussex, UK: John Wiley & Sons; 2013
   Google Scholar
• Lowinson JH. Substance abuse: a comprehensive textbook. Philadelphia: Lippincott Williams & Wilkins; 2005
   Google Scholar
• Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997;4:231–244
   PubMed Web of Science ®Google Scholar
• Khantzian EJ. The self-medication hypothesis revisited: the dually diagnosed patient. Primary Psychiatry 2003;10:47–54
   Google Scholar
• Sullivan MD, Edlund MJ, Steffick D, Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain 2005;119:95–103
   PubMed Web of Science ®Google Scholar
• Grella CE, Karno MP, Warda US, Niv N, Moore AA. Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addict Behav 2009;34:498–504
   PubMed Web of Science ®Google Scholar
• Huang B, Dawson DA, Stinson FS, Hasin DS, Ruan W, Saha TD, Smith SM, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006;67:1062–1073
   PubMed Web of Science ®Google Scholar
• Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 2008;94:38–47
   PubMed Web of Science ®Google Scholar
• Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction 2008;103:258–268
   PubMed Web of Science ®Google Scholar
• Fischer B, Lusted A, Roerecke M, Taylor B, Rehm J. The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis. J Pain 2012;13:1029–1044
   PubMed Web of Science ®Google Scholar
• Martins SS, Keyes KM, Storr CL, Zhu H, Chilcoat HD. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2009;103:16–24
   PubMed Web of Science ®Google Scholar
• Dowling KBA, Storr CLS, Chilcoat HDS. Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population. Clin J Pain 2006;22:76–783
   Google Scholar
• Martins SS, Fenton MC, Keyes KM, Blanco C, Zhu H, Storr CL. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med 2012;42:1261–1272
   PubMed Web of Science ®Google Scholar
• Schepis TS, Hakes JK. Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction 2011;106:2146–2155
   PubMed Web of Science ®Google Scholar
• McCauley JL, Danielson CK, Amstadter AB, Ruggiero KJ, Resnick HS, Hanson RF, Smith DW, et al. The role of traumatic event history in non-medical use of prescription drugs among a nationally representative sample of US adolescents. J Child Psychol Psychiatry 2010;51:84–93
   PubMed Web of Science ®Google Scholar
• Chilcoat HD, Breslau N. Posttraumatic stress disorder and drug disorders: testing causal pathways. Arch Gen Psychiatry 1998;55:913–917
   PubMed Web of Science ®Google Scholar
• McCauley JL, Amstadter AB, Danielson CK, Ruggiero KJ, Kilpatrick DG, Resnick HS. Mental health and rape history in relation to non-medical use of prescription drugs in a national sample of women. Addict Behav 2009;34:641–648
   PubMed Web of Science ®Google Scholar
• Chilcoat HD, Breslau N. Investigations of causal pathways between PTSD and drug use disorders. Addict Behav 1998;23:827–840
   PubMed Web of Science ®Google Scholar
• Jacobsen LK. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry 2001;158:1184–1190
   PubMed Web of Science ®Google Scholar
• Sung H-E, Richter L, Vaughan R, Johnson PB, Thom B. Nonmedical use of prescription opioids among teenagers in the United States: trends and correlates. J Adolesc Health 2005;37:44–51
   PubMed Web of Science ®Google Scholar
• McCabe SE, Boyd CJ, Teter CJ. Illicit use of opioid analgesics by high school seniors. J Subst Abuse Treat 2005;28:225–230
   PubMed Web of Science ®Google Scholar
• Ford JA. Nonmedical prescription drug use and delinquency: an analysis with a national sample. J Drug Issues 2008;38:493–516
   Web of Science ®Google Scholar
• Catalano RF, White HR, Fleming CB, Haggerty KP. Is nonmedical prescription opiate use a unique form of illicit drug use? Addict Behav 2011;36:79–86
   PubMed Web of Science ®Google Scholar
• Wong CF, Silva K, Kecojevic A, Schrager SM, Bloom JJ, Iverson E, Lankenau SE. Coping and emotion regulation profiles as predictors of nonmedical prescription drug and illicit drug use among high-risk young adults. Drug Alcohol Depend 2013;132:165–171
   PubMed Web of Science ®Google Scholar
• Mackesy-Amiti ME, Donenberg GR, Ouellet LJ. Prevalence of psychiatric disorders among young injection drug users. Drug Alcohol Depend 2012;124:70–78
   PubMed Web of Science ®Google Scholar
• Mackesy-Amiti ME, Donenberg GR, Ouellet LJ. Psychiatric correlates of injection risk behavior among young people who inject drugs. Psychol Addict Behav (in press)
   Google Scholar
• Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl 1997;44:174–199
   Web of Science ®Google Scholar
• Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl 2002;49:11–34
   Web of Science ®Google Scholar
• Hasin D, Trautman K, Endicott J. Psychiatric research interview for substance and mental disorders: phenomenologically based diagnosis in patients who abuse alcohol or drugs. Psychopharmacol Bull 1998;34:3–8
   PubMed Web of Science ®Google Scholar
• Hasin D, Trautman KD, Miele GM, Samet S, Smith M, Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry 1996;153:1195–1201
   PubMed Web of Science ®Google Scholar
• Caton CL, Drake RE, Hasin DS, Dominguez B, Shrout PE, Samet S, Schanzer WB. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch Gen Psychiatry 2005;62:137–145
   PubMed Web of Science ®Google Scholar
• Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry 2006;163:689–696
   PubMed Web of Science ®Google Scholar
• StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP; 2011
   Google Scholar
• Schonlau M, Liebau E. Respondent-driven sampling. Stata J 2012;12:72–93
   Web of Science ®Google Scholar
• Fendrich M, Mackesy-Amiti ME. Decreased drug reporting in a cross-sectional student drug use survey. J Subst Abuse 2000;11:161–172
   PubMedGoogle Scholar
• Fendrich M, Warner V. Symptom and substance use reporting consistency over two years for offspring at high and low risk for depression. J Abnorm Child Psychol 1994;22:425–439
   Google Scholar
• Darke S, Williamson A, Ross J, Teesson M, Lynskey M. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2004;74:77–83
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend 1997;48:135–141
   PubMed Web of Science ®Google Scholar
• Shand FL, Degenhardt L, Slade T, Nelson EC. Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence. Addict Behav 2010;36:27–36
   Google Scholar
• Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence: intake data from the National Treatment Outcome Research Study. Br J Psychiatry 2000;176:285–289
   PubMed Web of Science ®Google Scholar
• Wu LT, Woody GE, Yang C, Blazer DG. How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Addiction Med 2011;5:28–35
   PubMed Web of Science ®Google Scholar
• Subramaniam GA, Stitzer MA. Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder. Drug Alcohol Depend 2009;101:13–19
   PubMed Web of Science ®Google Scholar
• Mills KL, Lynskey M, Teesson M, Ross J, Darke S. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates. Drug Alcohol Depend 2005;77:243–249
   PubMed Web of Science ®Google Scholar
• Bremner JD, Southwick SM, Darnell A, Charney DS. Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry 1996;153:369–375
   PubMed Web of Science ®Google Scholar
• Villagonzalo K-A, Dodd S, Ng F, Mihaly S, Langbein A, Berk M. The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program. Compr Psychiatry 2011;52:562–566
   Google Scholar
• Tomlinson KL, Tate SR, Anderson KG, McCarthy DM, Brown SA. An examination of self-medication and rebound effects: psychiatric symptomatology before and after alcohol or drug relapse. Addict Behav 2006;31:461–474
   PubMed Web of Science ®Google Scholar
• Bolton JMD, Cox BP, Clara IMA, Sareen JMD. Use of alcohol and drugs to self-medicate anxiety disorders in a nationally representative sample. J Nerv Ment Dis 2006;194:818–825
   PubMed Web of Science ®Google Scholar